blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2264028

EP2264028 - Pyrazole compounds useful as protein kinase inhibitors [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  04.12.2015
Database last updated on 31.08.2024
Most recent event   Tooltip04.12.2015Application deemed to be withdrawnpublished on 06.01.2016  [2016/01]
Applicant(s)For all designated states
Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston, MA 02210 / US
[2014/35]
Former [2014/09]For all designated states
Vertex Pharmaceuticals Inc.
50 Northern Avenue
Boston, MA 02210 / US
Former [2010/51]For all designated states
VERTEX PHARMACEUTICALS INCORPORATED
130 Waverly Street
Cambridge, MA 02139-4242 / US
Inventor(s)01 / Bebbington, David
6 Linden Close
Newbury, Berkshire RG1 4QA / GB
02 / Charrier, Jean-Damien
Vertex Pharma. Inc Cottage Wing Station Rd Southa
Bishops Itchington, Oxfordshire CV47 2QB / GB
03 / Golec, Julian
8 Manor Farm Chapel Road
Ashbury, Wiltshire SN6 8LS / GB
04 / Miller, Andrew
Cherry Cottage Chilton Road Upton
Didcot, Oxfordshire OX11 9JL / GB
05 / Knegtel, Ronald
3 Bath Court Bath Street
Abingdon, Oxfordshire OX11 1EE / GB
 [2010/51]
Representative(s)Coles, Andrea Birgit, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2011/31]Coles, Andrea Birgit, et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ / GB
Former [2010/51]Coles, Andrea Birgit
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date10184271.419.12.2001
[2010/51]
Priority number, dateUS20000257887P21.12.2000         Original published format: US 257887 P
US20010286949P27.04.2001         Original published format: US 286949 P
[2010/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2264028
Date:22.12.2010
Language:EN
[2010/51]
Search report(s)(Supplementary) European search report - dispatched on:EP17.11.2010
ClassificationIPC:C07D401/14, C07D403/12, C07D401/12, C07D403/14, C07D405/14, C07D417/14, C07D487/04, C07D491/04, C07D495/04, A61K31/506, A61P35/00
[2015/09]
CPC:
C07D403/14 (EP,US); C07D401/12 (EP,KR,US); A61P1/00 (EP);
A61P11/06 (EP); A61P13/12 (EP); A61P15/00 (EP);
A61P17/06 (EP); A61P17/14 (EP); A61P19/02 (EP);
A61P19/08 (EP); A61P19/10 (EP); A61P21/00 (EP);
A61P21/02 (EP); A61P21/04 (EP); A61P25/00 (EP);
A61P25/02 (EP); A61P25/14 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P27/02 (EP); A61P29/00 (EP); A61P3/08 (EP);
A61P3/10 (EP); A61P3/14 (EP); A61P31/12 (EP);
A61P31/18 (EP); A61P31/20 (EP); A61P31/22 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P35/04 (EP);
A61P37/00 (EP); A61P37/02 (EP); A61P37/06 (EP);
A61P37/08 (EP); A61P43/00 (EP); A61P5/00 (EP);
A61P5/18 (EP); A61P9/00 (EP); A61P9/04 (EP);
A61P9/08 (EP); A61P9/10 (EP); C07D231/12 (EP,US);
C07D233/56 (EP,US); C07D249/08 (EP,US); C07D401/14 (EP,US);
C07D403/12 (EP,US); C07D405/14 (EP,US); C07D407/14 (EP,US);
C07D409/14 (EP,US); C07D417/14 (EP,US); C07D471/04 (EP,US);
C07D473/16 (EP,US); C07D487/04 (EP,US); C07D491/04 (EP,US);
C07D493/04 (EP,US); C07D495/04 (EP,US); C07D513/04 (EP,US) (-)
Former IPC [2010/51]C07D403/12, C07D401/14, A61K31/506, A61P35/00
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2010/51]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:Pyrazoleverbindungen als Protein- kinasehemmer[2010/51]
English:Pyrazole compounds useful as protein kinase inhibitors[2010/51]
French:Composés de pyrazole utiles en tant qu'inhibiteurs de protéine kinase[2010/51]
Examination procedure22.06.2011Amendment by applicant (claims and/or description)
22.06.2011Examination requested  [2011/31]
04.12.2012Despatch of a communication from the examining division (Time limit: M04)
10.04.2013Reply to a communication from the examining division
01.07.2013Despatch of a communication from the examining division (Time limit: M04)
25.10.2013Reply to a communication from the examining division
12.11.2013Despatch of a communication from the examining division (Time limit: M06)
22.05.2014Reply to a communication from the examining division
09.02.2015Communication of intention to grant the patent
20.06.2015Application deemed to be withdrawn, date of legal effect  [2016/01]
31.07.2015Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2016/01]
Parent application(s)   TooltipEP01994323.2  / EP1353916
EP06011799.1  / EP1702920
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010994323) is  29.01.2004
Fees paidRenewal fee
13.01.2011Renewal fee patent year 03
13.01.2011Renewal fee patent year 04
13.01.2011Renewal fee patent year 05
13.01.2011Renewal fee patent year 06
13.01.2011Renewal fee patent year 07
13.01.2011Renewal fee patent year 08
13.01.2011Renewal fee patent year 09
27.12.2010Renewal fee patent year 10
27.12.2011Renewal fee patent year 11
26.12.2012Renewal fee patent year 12
27.12.2013Renewal fee patent year 13
19.12.2014Renewal fee patent year 14
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Rights in Rem or Legal Means of ExecutionID:01
For:AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR
Date:31.10.2014
[2014/51]
Documents cited:Search[A]WO0021955  (ZENECA LTD [GB], et al) [A] 1,2* examples 16-20 *;
 [A]WO0039101  (ASTRAZENECA UK LTD [GB], et al) [A] 1,2 * the whole document *
ExaminationWO0160816
by applicantUS2585906
 WO9965897
 WO0012497
 WO0038675
    - BISCHOFF ET AL., EMBO J., (1998), vol. 17, pages 3052 - 3065
    - SCHUMACHER ET AL., J. CELL BIOL., (1998), vol. 143, pages 1635 - 1646
    - KIMURA ET AL., J. BIOL. CHEM., (1997), vol. 272, pages 13766 - 13771
    - COGHLAN ET AL., CHEMISTRY & BIOLOGY, (2000), vol. 7, pages 793 - 803
    - KIM; KIMMEL, CURR. OPINION GENETICS DEV., (2000), vol. 10, pages 508 - 514
    - HAQ ET AL., J. CELL BIOL., (2000), vol. 151, page 117
    - KLEIN ET AL., PNAS, (1996), vol. 93, pages 8455 - 9
    - CROSS ET AL., BIOCHEM. J., (1994), vol. 303, pages 21 - 26
    - COHEN, BIOCHEM. SOC. TRANS., (1993), vol. 21, pages 555 - 567
    - MASSILLON ET AL., BIOCHEM J., (1994), vol. 299, pages 123 - 128
    - LAVESTONE ET AL., CURRENT BIOLOGY, (1994), vol. 4, pages 1077 - B6
    - BROWNLEES ET AL., NEUROREPORT, (1997), vol. 8, pages 3251 - 55
    - ZHONG ET AL., NATURE, (1998), vol. 395, pages 698 - 702
    - TAKASHIMA ET AL., PNAS, (1993), vol. 90, pages 7789 - 93
    - PEI ET AL., J. NEUROPATHOL. EXP, (1997), vol. 56, pages 70 - 78
    - FISCHER, P.M.; LANE, D.P., CURRENT MEDICINAL CHEMISTRY, (2000), vol. 7, pages 1233 - 1245
    - MANI, S.; WANG, C.; WU, K.; FRANCIS, R.; PESTEL, R., EXP. OPIN. INVEST. DRUGS, (2000), vol. 9, page 1849
    - FRY, D.W.; GARRETT, M.D., "Current Opinion in Oncologic", ENDOCRINE & METABOLIC INVESTIGATIONAL DRUGS, (2000), vol. 2, pages 40 - 59
    - KHWAJA, A., NATURE, (1990), pages 33 - 34
    - ZANG, Q. Y. ET AL., ONCOGENE, (2000), vol. 19
    - KAZUHIKO, N. ET AL., THE JOURNAL OF NEUROSCIENCE, (2000), vol. 20
    - SORIANO, CELL, (1992), vol. 69, page 551
    - SORIANO ET AL., CELL, (1991), vol. 64, page 693
    - TAKAYANAGI, J. CLIN. INVEST., (1999), vol. 104, page 137
    - BOSCHELLI, DRUGS OF THE FUTURE 2000, (2000), vol. 25, no. 7, page 717
    - TALAMONTI, J. CLIN. INVEST., (1993), vol. 91, page 53
    - LUTZ, BIOCHEM. BIOPHYS. RES., (1998), vol. 243, page 503
    - ROSEN, J. BIOL. CHEM., (1986), vol. 261, page 13754
    - BOLEN, PROC. NATL. ACAD. SCI. USA, (1987), vol. 84, page 2251
    - MASAKI, HEPATOLOGY, (1998), vol. 27, page 1257
    - BISCARDI, ADV. CANCER RES., (1999), vol. 76, page 61
    - LYNCH, LEUKEMIA, (1993), vol. 7, page 1416
    - WIENER, CLIN. CANCER RES., (1999), vol. 5, page 2164
    - STALEY, CELL GROWTH DIFF., (1997), vol. 8, page 269
    - MOLINA ET AL., NATURE, (1992), vol. 357, page 161
    - J. INDIAN. CHEM. SOC., (1984), vol. 61, pages 690 - 693
    - J. MED. CHEM., (1994), vol. 37, pages 3828 - 3833
    - BIOORG. MED. CHEM. LETT, (2000), vol. 10, no. 11, pages 1175 - 1180
    - J. HET. CHEM, (1984), vol. 21, pages 1161 - 1167
    - J. MED. CHEM, (1995), vol. 38, no. 14, pages 2763 - 2773
    - CHEM. PHARM. BULL., (1992), vol. 40, no. 1, pages 227 - 229
    - J. HET. CHEM., (1984), vol. 21, pages 1161 - 1167
    - BIOORG. MED. CHEM. LETT, (1998), vol. 8, no. 20, pages 2891 - 2896
    - CHEM. HETEROCYCL. COMPD., (1999), vol. 35, no. 7, pages 818 - 820
    - J. CHEM. SECT. B, (1983), vol. 22, no. 1, pages 37 - 42
    - PESTIC. SCI, (1996), vol. 47, no. 2, pages 103 - 114
    - J. MED. CHEM., (1980), vol. 23, no. 8, pages 913 - 918
    - PHARMAZIE, (1988), vol. 43, no. 7, pages 475 - 476
    - J. MED. CHEM., (2000), vol. 43, no. 22, pages 4288 - 4312
    - J. MED. CHEM., (1998), vol. 41, no. 20, pages 3793 - 3803
    - J. MED. CHEM., (1995), vol. 38, no. 14, pages 2763 - 2773
    - BIOORG. MED. CHEM. LETT., (1997), vol. 7, no. 4, pages 421 - 424
    - BIOORG. MED. CHEM. LETT., (2000), vol. 10, no. 8, pages 703 - 706
    - J. MED. CHEM., (1998), vol. 41, no. 21, pages 4021 - 4035
    - J. AM. CHEM. SOC., (1959), vol. 81, pages 5997 - 6006
    - BIOORG. MED. CHEM. LETT., (2000), vol. 10, no. 8, pages 821 - 826
    - J. MED. CHEM., (1984), vol. 27, no. 12, pages 1621 - 1629
    - INDIAN J. CHEM. SECT. B, (1995), vol. 34, no. 9, pages 778 - 790
    - J. CHEM. SOC., (1947), pages 899 - 905
    - J. CHEM. SOC., (1948), vol. 34, no. 9, pages 777 - 782
    - INDIAN J. CHEM., (1967), pages 467 - 470
    - JEFFERY, J. E. ET AL., J. CHEM SOC, (1996), pages 2583 - 2589
    - GNECCO, D. ET AL., ORG PREP PROCED INT, (1996), vol. 28, no. 4, pages 478 - 480
    - FEDORYNSKI, M.; JONCZYK, A., ORG PREP PROCED INT, (1995), vol. 27, no. 3, pages 355 - 359
    - SUZUKI, S ET AL., CAN J CHEM, (1994), vol. 71, no. 2, pages 357 - 361
    - PRASAD, G. ET AL., J ORG CHEM, (1991), pages 7188 - 7190
    - MOSS, R. ET AL., TETRAHEDRON LETT, (1995), pages 8761 - 8764
    - GARIGIPATI, R., TETRAHEDRON LETT, (1990), pages 1969 - 1972
    - FOX ET AL., PROTEIN SCI., (1998), vol. 7, page 2249
    - FOX ET AL., PROTEIN SCI, (1998), vol. 7, page 2249
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.